TNXP James Treco buys $9K worth of shares
Aug 21, 2025, 4:33 AM
0.00%
What does TNXP do
Tonix Pharmaceuticals Holding, based in Chatham, New Jersey, specializes in developing therapeutics for CNS disorders and immunology, with a portfolio including TNX-102 SL for fibromyalgia and TNX-1500 for autoimmune diseases. Founded in 2010, the company employs 103 people and markets Zembrace SymTouch and Tosymra.
James Treco bought 250 shares of TNXP on 20 August at $36.00 per share, worth a total of $9K. They now own 250 TNXP shares.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.